ASTRON PERIPHERAL SELF-EXPANDING NITINOL STENT SYSTEM
Biotronik AG · Decision date Dec 17, 2015
What did the FDA approve?
The FDA database entry for P140030 records a December 17, 2015 approval decision for the Astron Peripheral Self-Expanding Nitinol Stent System from Biotronik AG. The device is categorized as an iliac stent under product code NIO and specialty Cardiovascular.
The approval statement describes the indicated use as improving luminal diameter in patients with iliac atherosclerotic lesions in vessel reference diameters between 4.3 mm and 9.5 mm and lesion lengths up to 105 mm. The entry does not identify a supplement type or supplement reason, and no additional clinical performance data are included.
FDA approval order statement
APPROVAL FOR THE ASTRON PERIPHERAL SELF-EXPANDING STENT SYSTEM. THIS DEVICE IS INDICATED FOR IMPROVING LUMINAL DIAMETERIN PATIENTS WITH ILIAC ATHEROSCLEROTIC LESIONS IN VESSEL REFERENCE DIAMETERS BETWEEN 4.3MM AND9.5MM AND LESION LENGTHS UP TO 105MM.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 17, 2015
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P140030
- Regulatory pathway
- Premarket approval application
- Applicant
- Biotronik AG
- Product code
- NIO
- Decision code
- APPR
- Decision date
- Dec 17, 2015
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, ILIAC.
- Applicant
- Biotronik AG
- Product code
- NIO
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P140030 received
Application receipt date recorded by FDA.
P140030 · FDA decision
APPR
P140030/S025 · Related supplement
Astron Peripheral Self-Expanding Nitinol Stent System
Timeline entries are records held by MedtechLedger for P140030. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140030
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA |
Explore the linked device profile
Other records with product code NIO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook Ireland, Ltd. | PMA supplement | Nov 6, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
S.M.A.R.T. CONTROL Nitinol Stent SystemP020036/S061 | Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA |
ZILVER VASCULAR STENTP050017 | Cook Ireland, Ltd. | PMA approval | Jun 26, 2006 | FDA |
INTRASTENT DOUBLESTRUT STENTP030045 | Medtronic Vascular, Inc. | PMA approval | Jun 8, 2004 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Biotronik AG
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Ackerstrasse 6, Bülach, 8180
Sources and methodology
- Original FDA record: P140030
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




